Co-Partners
Associate Partners
Get App

Co-Partners

Associate Partners

Last Updated : Apr 12, 2019 01:15 PM IST | Source: Moneycontrol.com

Jubilant Life Sciences Q4 PAT seen up 36.3% YoY to Rs. 211.2 cr: Prabhudas Lilladher

Net Sales are expected to increase by 3.8 percent Y-o-Y (down 1.7 percent Q-o-Q) to Rs. 2,336.5 crore, according to Prabhudas Lilladher.

Moneycontrol News @moneycontrolcom
Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Jubilant Life Sciences to report net profit at Rs. 211.2 crore up 36.3% year-on-year (down 19% quarter-on-quarter).


Net Sales are expected to increase by 3.8 percent Y-o-Y (down 1.7 percent Q-o-Q) to Rs. 2,336.5 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 1.7 percent Y-o-Y (down 8.7 percent Q-o-Q) to Rs. 450.1 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Apr 12, 2019 01:15 pm
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant